These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


1517 related items for PubMed ID: 24335877

  • 1. Kit preparation and biokinetics in women of 99mTc-EDDA/HYNIC-E-[c(RGDfK)]2 for breast cancer imaging.
    Ortiz-Arzate Z, Santos-Cuevas CL, Ocampo-García BE, Ferro-Flores G, García-Becerra R, Estrada G, Gómez-Argumosa E, Izquierdo-Sánchez V.
    Nucl Med Commun; 2014 Apr; 35(4):423-32. PubMed ID: 24335877
    [Abstract] [Full Text] [Related]

  • 2. 99mTc-labeled PSMA inhibitor: Biokinetics and radiation dosimetry in healthy subjects and imaging of prostate cancer tumors in patients.
    Santos-Cuevas C, Davanzo J, Ferro-Flores G, García-Pérez FO, Ocampo-García B, Ignacio-Alvarez E, Gómez-Argumosa E, Pedraza-López M.
    Nucl Med Biol; 2017 Sep; 52():1-6. PubMed ID: 28575794
    [Abstract] [Full Text] [Related]

  • 3. Targeted imaging of gastrin-releasing peptide receptors with 99mTc-EDDA/HYNIC-[Lys3]-bombesin: biokinetics and dosimetry in women.
    Santos-Cuevas CL, Ferro-Flores G, Arteaga de Murphy C, Pichardo-Romero PA.
    Nucl Med Commun; 2008 Aug; 29(8):741-7. PubMed ID: 18753829
    [Abstract] [Full Text] [Related]

  • 4. 99mTc-exendin(9-39)/octreotide: biokinetics and radiation dosimetry in healthy individuals.
    Ocampo-García BE, Santos-Cuevas CL, Luna-Gutiérrez MA, Ignacio-Alvarez E, Pedraza-López M, Manzano-Mayoral C.
    Nucl Med Commun; 2017 Nov; 38(11):912-918. PubMed ID: 28953210
    [Abstract] [Full Text] [Related]

  • 5. [99mTc]HYNIC-RGD for imaging integrin alphavbeta3 expression.
    Decristoforo C, Faintuch-Linkowski B, Rey A, von Guggenberg E, Rupprich M, Hernandez-Gonzales I, Rodrigo T, Haubner R.
    Nucl Med Biol; 2006 Nov; 33(8):945-52. PubMed ID: 17127166
    [Abstract] [Full Text] [Related]

  • 6. Clinical translation of a PSMA inhibitor for 99mTc-based SPECT.
    Ferro-Flores G, Luna-Gutiérrez M, Ocampo-García B, Santos-Cuevas C, Azorín-Vega E, Jiménez-Mancilla N, Orocio-Rodríguez E, Davanzo J, García-Pérez FO.
    Nucl Med Biol; 2017 May; 48():36-44. PubMed ID: 28193503
    [Abstract] [Full Text] [Related]

  • 7. Biokinetics and dosimetry in patients of 99mTc-EDDA/HYNIC-Tyr3-octreotide prepared from lyophilized kits.
    González-Vázquez A, Ferro-Flores G, Arteaga de Murphy C, Gutiérrez-García Z.
    Appl Radiat Isot; 2006 Jul; 64(7):792-7. PubMed ID: 16542847
    [Abstract] [Full Text] [Related]

  • 8. An improved kit formulation for one-pot synthesis of [99m Tc]Tc-HYNIC-E[c(RGDfK)]2 for routine clinical use in cancer imaging.
    Chakraborty S, Das S, Chakravarty R, Sarma HD, Vatsa R, Shukla J, Mittal BR, Dash A.
    J Labelled Comp Radiopharm; 2019 Oct; 62(12):823-834. PubMed ID: 31315149
    [Abstract] [Full Text] [Related]

  • 9. Improved radiopharmaceutical based on 99mTc-Bombesin-folate for breast tumour imaging.
    Aranda-Lara L, Ferro-Flores G, Ramírez Fde M, Ocampo-García B, Santos-Cuevas C, Díaz-Nieto L, Isaac-Olivé K.
    Nucl Med Commun; 2016 Apr; 37(4):377-86. PubMed ID: 26657220
    [Abstract] [Full Text] [Related]

  • 10. Kit for preparation of multimeric receptor-specific ⁹⁹mTc-radiopharmaceuticals based on gold nanoparticles.
    Ocampo-García B, Ferro-Flores G, Morales-Avila E, Ramírez Fde M.
    Nucl Med Commun; 2011 Nov; 32(11):1095-104. PubMed ID: 21860334
    [Abstract] [Full Text] [Related]

  • 11. Design and biological evaluation of ⁹⁹mTc-N₂S₂-Tat(49-57)-c(RGDyK): a hybrid radiopharmaceutical for tumors expressing α(v)β(3) integrins.
    Ocampo-García BE, Santos-Cuevas CL, De León-Rodríguez LM, García-Becerra R, Ordaz-Rosado D, Luna-Guitiérrez MA, Jiménez-Mancilla NP, Romero-Piña ME, Ferro-Flores G.
    Nucl Med Biol; 2013 May; 40(4):481-7. PubMed ID: 23618768
    [Abstract] [Full Text] [Related]

  • 12. Preliminary application of micro-SPECT/CT imaging by 99m Tc-tricine-EDDA-HYNIC-c-Met for non-small-cell lung cancer.
    Zhang Y, Meng L, Li B, Tan H, Lin QY, Cheng D, Shi H.
    Chem Biol Drug Des; 2019 Apr; 93(4):447-453. PubMed ID: 30381892
    [Abstract] [Full Text] [Related]

  • 13. 99mTc-HYNIC-(tricine/EDDA)-FROP peptide for MCF-7 breast tumor targeting and imaging.
    Ahmadpour S, Noaparast Z, Abedi SM, Hosseinimehr SJ.
    J Biomed Sci; 2018 Feb 19; 25(1):17. PubMed ID: 29455647
    [Abstract] [Full Text] [Related]

  • 14. Evaluation of a (99m)Tc-labeled cyclic RGD tetramer for noninvasive imaging integrin alpha(v)beta3-positive breast cancer.
    Liu S, Hsieh WY, Jiang Y, Kim YS, Sreerama SG, Chen X, Jia B, Wang F.
    Bioconjug Chem; 2007 Feb 19; 18(2):438-46. PubMed ID: 17341108
    [Abstract] [Full Text] [Related]

  • 15. 177Lu-DOTA-HYNIC-Lys(Nal)-Urea-Glu: Biokinetics, Dosimetry, and Evaluation in Patients with Advanced Prostate Cancer.
    Santos-Cuevas C, Ferro-Flores G, García-Pérez FO, Jiménez-Mancilla N, Ramírez-Nava G, Ocampo-García B, Luna-Gutiérrez M, Azorín-Vega E, Davanzo J, Soldevilla-Gallardo I.
    Contrast Media Mol Imaging; 2018 Feb 19; 2018():5247153. PubMed ID: 30534027
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of (99m)Tc-HYNIC-TMTP1 as a tumor-homing imaging agent targeting metastasis with SPECT.
    Li F, Cheng T, Dong Q, Wei R, Zhang Z, Luo D, Ma X, Wang S, Gao Q, Ma D, Zhu X, Xi L.
    Nucl Med Biol; 2015 Mar 19; 42(3):256-62. PubMed ID: 25516099
    [Abstract] [Full Text] [Related]

  • 17. Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers.
    Wang L, Shi J, Kim YS, Zhai S, Jia B, Zhao H, Liu Z, Wang F, Chen X, Liu S.
    Mol Pharm; 2009 Mar 19; 6(1):231-45. PubMed ID: 19067525
    [Abstract] [Full Text] [Related]

  • 18. Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours.
    Ferro-Flores G, Arteaga de Murphy C, Rodriguez-Cortés J, Pedraza-López M, Ramírez-Iglesias MT.
    Nucl Med Commun; 2006 Apr 19; 27(4):371-6. PubMed ID: 16531924
    [Abstract] [Full Text] [Related]

  • 19. Multimeric system of 99mTc-labeled gold nanoparticles conjugated to c[RGDfK(C)] for molecular imaging of tumor α(v)β(3) expression.
    Morales-Avila E, Ferro-Flores G, Ocampo-García BE, De León-Rodríguez LM, Santos-Cuevas CL, García-Becerra R, Medina LA, Gómez-Oliván L.
    Bioconjug Chem; 2011 May 18; 22(5):913-22. PubMed ID: 21513349
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 76.